150 related articles for article (PubMed ID: 38667446)
1. Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel.
Maloberti T; De Leo A; Coluccelli S; Sanza V; Gruppioni E; Altimari A; Comito F; Melotti B; Marchese PV; Dika E; Venturi F; Corti B; Ciccimarra G; Ciceu CA; Tallini G; de Biase D
Diagnostics (Basel); 2024 Apr; 14(8):. PubMed ID: 38667446
[TBL] [Abstract][Full Text] [Related]
2. Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.
Diefenbach RJ; Lee JH; Stewart A; Menzies AM; Carlino MS; Saw RPM; Stretch JR; Long GV; Scolyer RA; Rizos H
Front Oncol; 2022; 12():820510. PubMed ID: 35494035
[TBL] [Abstract][Full Text] [Related]
3. Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients.
Castillo P; Marginet M; Jares P; García M; Gonzalvo E; Arance A; García A; Alos L; Teixido C
Explor Target Antitumor Ther; 2020; 1(2):101-108. PubMed ID: 36046072
[TBL] [Abstract][Full Text] [Related]
4. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Diagnostic Yield of Targeted Next-Generation Sequencing for Melanoma and Gastrointestinal Tumors.
Garg S; Grenier S; Misyura M; Sukhai MA; Thomas M; Kamel-Reid S; Stockley T
J Mol Diagn; 2020 Apr; 22(4):467-475. PubMed ID: 32036084
[TBL] [Abstract][Full Text] [Related]
6. Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).
Vanni I; Casula M; Pastorino L; Manca A; Dalmasso B; Andreotti V; Pisano M; Colombino M; ; Pfeffer U; Tanda ET; Rozzo C; Paliogiannis P; Cossu A; Ghiorzo P; Palmieri G;
Diagn Pathol; 2020 Dec; 15(1):143. PubMed ID: 33317587
[TBL] [Abstract][Full Text] [Related]
7. Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach.
Manca A; Paliogiannis P; Colombino M; Casula M; Lissia A; Botti G; Caracò C; Ascierto PA; Sini MC; Palomba G; Pisano M; ; ; Doneddu V; Cossu A; Palmieri G;
J Transl Med; 2019 Aug; 17(1):289. PubMed ID: 31455347
[TBL] [Abstract][Full Text] [Related]
8. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
Siroy AE; Boland GM; Milton DR; Roszik J; Frankian S; Malke J; Haydu L; Prieto VG; Tetzlaff M; Ivan D; Wang WL; Torres-Cabala C; Curry J; Roy-Chowdhuri S; Broaddus R; Rashid A; Stewart J; Gershenwald JE; Amaria RN; Patel SP; Papadopoulos NE; Bedikian A; Hwu WJ; Hwu P; Diab A; Woodman SE; Aldape KD; Luthra R; Patel KP; Shaw KR; Mills GB; Mendelsohn J; Meric-Bernstam F; Kim KB; Routbort MJ; Lazar AJ; Davies MA
J Invest Dermatol; 2015 Feb; 135(2):508-515. PubMed ID: 25148578
[TBL] [Abstract][Full Text] [Related]
9. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
10. Clinical Application of Next-Generation Sequencing-Based Panel to
Park C; Kim M; Kim MJ; Kim H; Ock CY; Keam B; Kim TM; Kim DW; Kim JI; Heo DS
Mol Cancer Ther; 2020 Mar; 19(3):937-944. PubMed ID: 31826932
[TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel.
de Biase D; Acquaviva G; Visani M; Sanza V; Argento CM; De Leo A; Maloberti T; Pession A; Tallini G
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32340363
[TBL] [Abstract][Full Text] [Related]
12. Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation.
Fernandes MGO; Jacob M; Martins N; Moura CS; Guimarães S; Reis JP; Justino A; Pina MJ; Cirnes L; Sousa C; Pinto J; Marques JA; Machado JC; Hespanhol V; Costa JL
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31443496
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
Bonanno L; Pavan A; Ferro A; Calvetti L; Frega S; Pasello G; Aprile G; Guarneri V; Conte P;
Oncologist; 2020 Dec; 25(12):e1996-e2005. PubMed ID: 32557976
[TBL] [Abstract][Full Text] [Related]
14. Targeted next generation sequencing (NGS) to classify melanocytic neoplasms.
Zarabi SK; Azzato EM; Tu ZJ; Ni Y; Billings SD; Arbesman J; Funchain P; Gastman B; Farkas DH; Ko JS
J Cutan Pathol; 2020 Aug; 47(8):691-704. PubMed ID: 32291779
[TBL] [Abstract][Full Text] [Related]
15. A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications.
Tirrò E; Massimino M; Broggi G; Romano C; Minasi S; Gianno F; Antonelli M; Motta G; Certo F; Altieri R; Manzella L; Caltabiano R; Barbagallo GMV; Buttarelli FR; Magro G; Giangaspero F; Vigneri P
Front Oncol; 2022; 12():861078. PubMed ID: 35372034
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers.
Kang SY; Kim DG; Kim H; Cho YA; Ha SY; Kwon GY; Jang KT; Kim KM
BMC Med Genomics; 2022 Feb; 15(1):25. PubMed ID: 35135543
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.
Bregni G; Sticca T; Camera S; Akin Telli T; Craciun L; Trevisi E; Pretta A; Kehagias P; Leduc S; Senti C; Deleporte A; Vandeputte C; Saad ED; Kerger J; Gil T; Piccart-Gebhart M; Awada A; Demetter P; Larsimont D; Hendlisz A; Aftimos P; Sclafani F
Acta Oncol; 2020 Dec; 59(12):1438-1446. PubMed ID: 32820683
[TBL] [Abstract][Full Text] [Related]
18. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
19. Identification of fusions with potential clinical significance in melanoma.
Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
[TBL] [Abstract][Full Text] [Related]
20. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
